Mycobactin S is made from metabolic products of the acid- resistant form of Mycobacterium phlei, a tuberculosis bacillus derived originally from the cold-blooded sea turtle. Importantly, it is not based on cell wall fragments or killed bacteria. Non-pathogenic to humans, this medication modulates the immune response and is highly effective against all types of tuberculosis including lung, skeletal, bone, skin and other tissues.
